Other

2027

Moderna 2027 decreased by 23.1% to $20.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $24.00M to $20.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ2 2020
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase indicates higher short-term cash requirements for lease obligations, potentially impacting liquidity, while a decrease suggests reduced short-term lease-related cash outflows.

Detailed definition

This metric captures the total cash outflows required to satisfy finance lease obligations within the upcoming twelve-mo...

Peer comparison

Commonly disclosed in the maturity analysis of lease liabilities for financial institutions.

Metric ID: other_finance_lease_liability_payments_due_next_twelve_months

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$174.00M$173.00M$39.00M$38.00M$136.00M$128.00M$198.00M$21.00M$22.00M$22.00M$47.00M$24.00M$27.00M$26.00M$20.00M
QoQ Change-0.6%-77.5%-2.6%+257.9%-5.9%+54.7%-89.4%+4.8%+0.0%+113.6%-48.9%+12.5%-3.7%-23.1%
YoY Change-78.2%-21.4%+228.2%+421.1%-84.6%-82.8%-88.9%+123.8%+9.1%+22.7%-44.7%-16.7%
Range$20.00M$198.00M
CAGR-46.1%
Avg YoY Growth+32.3%
Median YoY Growth-19.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's 2027?
Moderna (MRNA) reported 2027 of $20.00M in Q1 2026.
How has Moderna's 2027 changed year-over-year?
Moderna's 2027 decreased by 16.7% year-over-year, from $24.00M to $20.00M.
What does 2027 mean?
The total amount of finance lease payments due within the next year.